Research paperPathology of roots, spinal cord and brainstem in syringomyelia-like syndrome of Tangier disease
References (26)
- et al.
Familial alpha-lipoprotein deficiency (Tangier disease) with neurological abnormalities
Lancet
(1967) - et al.
Neurons and neuronal reaction in disease states
- et al.
Pathology of Tangier disease
J. Clin. Pathol.
(1971) - et al.
Tangier disease (alpha lipoprotein deficiency)
JAMA
(1977) - et al.
Adultonset of Tangier disease, Morphometric and pathologic studies suggesting delayed degradation of neutral lipids after fiber degeneration
J. Neuropathol. Exp. Neurol.
(1978) - et al.
Pathologic alterations of the peripheral nervous system of humans
- et al.
Neuropathy in Tangier disease
Alpha-lipoprotein deficiency manifesting as familial recurrent neuropathy and intestinal lipid storage
Arch. Neurol.
(1967) - et al.
The pathology of Tangier disease
A light and electron-microscopic study
Am. J. Pathol.
(1975) - et al.
Tangier disease: combined clinical staff conference at the National Institute of Health
Ann. Intern. Med.
(1961) - et al.
Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy
J. Neurol.
(1985)
Tangier disease
Brain
Licht und elektronen-mikroskopische sowie cytometrische Untersuchungen an peripheren Nerven bei Morbus Tangier
Acta Neuropathol. (Berl.)
Familial lipoprotein deficiency
Cited by (25)
Lipoprotein Disorders
2014, Encyclopedia of the Neurological SciencesLiver X receptor activation restores memory in aged AD mice without reducing amyloid
2011, Neurobiology of AgingCitation Excerpt :Increasing evidence indicates a link between AD and cholesterol metabolism (Marx, 2001; Ye et al., 2005; Hirsch-Reinshagen et al., 2008). Disturbances in cholesterol metabolism have been linked to neurological disorders such as Smith-Lemli-Opitz syndrome, Niemann-Pick disease type C, Tangier disease, Huntington's disease, and recently also to AD (Antoine et al., 1991; Tint et al., 1995; Repa et al., 2007; Milagre et al., 2008; Zhang et al., 2008). A link between cholesterol and AD is supported by the fact that APOE4, one of the three common human variants, E2, E3 and E4, is a major genetic risk factor for sporadic AD (Corder et al., 1993).
Facial onset sensory and motor neuronopathy (FOSMN) syndrome responding to immunotherapies
2008, Journal of the Neurological SciencesCitation Excerpt :The present case fits well with their description of illness. Syringomyelia-like syndromes such as, Tangier disease [2,3], chronic sensory ataxic neuropathy with ant-disialosyl IgM antibodies [4], sarcoid neuropathy, [5], Sjogren's neuropathy [6], a pharyngeal–cervical–brachial variant of Guillain–Barré syndrome [7–9], primary amyloidosis with cranial neuropathy [10] and other conditions simulating FOSMN syndrome were excluded based on symptoms and laboratory data. A neurodegenerative process was proposed because of the absence of inflammatory cell infiltrates in the nervous tissues and the lack of response to various immunotherapies [1].
Tangier Disease and Neuropathy
2005, Peripheral Neuropathy: 2-Volume Set with Expert Consult BasicPathology of Peripheral Neuron Cell Bodies
2005, Peripheral Neuropathy: 2-Volume Set with Expert Consult BasicTangier Disease and Neuropathy
2005, Peripheral Neuropathy